Federated Hermes’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,723
Closed -$11K 2431
2019
Q4
$11K Sell
2,723
-12,984
-83% -$61K ﹤0.01% 1897
2019
Q3
$77K Buy
15,707
+626
+4% +$3.5K ﹤0.01% 1683
2019
Q2
$92K Buy
15,081
+13,721
+1,009% +$72.9K ﹤0.01% 1613
2019
Q1
$8K Sell
1,360
-124
-8% -$1.28K ﹤0.01% 1914
2018
Q4
$20K Sell
1,484
-162
-10% -$2.73K ﹤0.01% 1778
2018
Q3
$32K Sell
1,646
-271
-14% -$5.77K ﹤0.01% 1795
2018
Q2
$49K Buy
1,917
+255
+15% +$5.95K ﹤0.01% 1695
2018
Q1
$33K Sell
1,662
-1,864
-53% -$43.5K ﹤0.01% 1696
2017
Q4
$71K Buy
3,526
+1,910
+118% +$37.6K ﹤0.01% 1630
2017
Q3
$33K Buy
1,616
+835
+107% +$14.1K ﹤0.01% 1693
2017
Q2
$12K Sell
781
-102,476
-99% -$1.71M ﹤0.01% 1814
2017
Q1
$1.65M Buy
103,257
+68,841
+200% +$993K ﹤0.01% 989
2016
Q4
$433K Buy
+34,416
New +$641K ﹤0.01% 1350
2016
Q3
Sell
-456,300
Closed -$16M 2197
2016
Q2
$16M Sell
456,300
-380,903
-45% -$12M 0.05% 319
2016
Q1
$22.9M Sell
837,203
-209,277
-20% -$6.16M 0.07% 243
2015
Q4
$35.8M Buy
1,046,480
+680
+0.1% +$21.2K 0.11% 171
2015
Q3
$30M Sell
1,045,800
-177,400
-15% -$7.59M 0.1% 208
2015
Q2
$54.7M Sell
1,223,200
-98,900
-7% -$3.72M 0.16% 133
2015
Q1
$45.7M Buy
1,322,100
+805,340
+156% +$21.9M 0.14% 154
2014
Q4
$14.1M Buy
+516,760
New +$12.5M 0.04% 361

Other funds holding DPLO

Federated Hermes's DPLO Position: Q1 2020 in Review

Federated Hermes sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 2,723 shares — an estimated $11K sold.

Federated Hermes first reported a position in DPLO in Q4 2014 and held it in 20 quarters. The position peaked at $54.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Federated Hermes reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Federated Hermes sold 2,723 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $11K.
  • Federated Hermes first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 20 quarters.
  • Federated Hermes's DIPLOMAT PHARMACY, INC. position peaked at $54.7M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.